BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20828948)

  • 1. Women's voices in the menopause: results from an international survey on vaginal atrophy.
    Nappi RE; Kokot-Kierepa M
    Maturitas; 2010 Nov; 67(3):233-8. PubMed ID: 20828948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
    Nappi RE; Kokot-Kierepa M
    Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey.
    Simon JA; Kokot-Kierepa M; Goldstein J; Nappi RE
    Menopause; 2013 Oct; 20(10):1043-8. PubMed ID: 23571518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
    Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.
    Nappi RE; Kingsberg S; Maamari R; Simon J
    J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.
    Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S
    Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.
    Utian WH; Maamari R
    Climacteric; 2014 Feb; 17(1):29-36. PubMed ID: 24083795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
    Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
    J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK.
    Domoney C; Currie H; Panay N; Maamari R; Nappi RE
    Menopause Int; 2013 Jun; 19(2):69-76. PubMed ID: 23778561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history.
    Kingsberg SA; Larkin L; Krychman M; Parish SJ; Bernick B; Mirkin S
    Menopause; 2019 Feb; 26(2):124-131. PubMed ID: 30130293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.
    Kingsberg SA; Krychman M; Graham S; Bernick B; Mirkin S
    J Sex Med; 2017 Mar; 14(3):413-424. PubMed ID: 28202320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of postmenopausal symptoms in North America and Europe.
    Minkin MJ; Reiter S; Maamari R
    Menopause; 2015 Nov; 22(11):1231-8. PubMed ID: 25944521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil.
    Pompei LM; Wender MCO; de Melo NR; Kulak J; Pardini D; Machado RB; Fernandes CE; Palacios S; Nappi RE
    Climacteric; 2021 Apr; 24(2):157-163. PubMed ID: 32869682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study.
    Domoney C; Short H; Particco M; Panay N
    Post Reprod Health; 2020 Jun; 26(2):101-109. PubMed ID: 32627698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.